This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

Kaye Scholer Advises Shareholders in €130M Sale of Activaero GmbH to Vectura Group

March 13, 2014

A team of Kaye Scholer lawyers in our Frankfurt, London and New York offices advised the shareholders of Activaero GmbH, Gmünden in the sale of all their shares to Vectura Group plc for a total of €130 million, funded through a combination of cash payments and Vectura shares.

Activaero is a private German pharmaceutical company originating from Helmholtz Zentrum München and providing novel solutions for severe respiratory diseases. Vectura is a UK-based product development company, listed on the London Stock Exchange (LSE: VEC), which focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. The acquisition of Activaero fulfills a number of strategic priorities for Vectura in a single transaction, including making the company a therapeutic area specialist for airways diseases.

The Kaye Scholer team advising the Activaero shareholders includes Special Counsel Gottfried Freier, Partner Stuart Fleet, and Associates Klaus Alten and Amy Utley (Corporate); Partners Martin Weger and Daniel Lewin and Associate Felix Haug (Tax); Associate Tim Luchtenberg (Employment & Labor); Associate Alexander Druckenbrodt (Complex Commercial Litigation); Counsel Marci Settle (Corporate) and Partner David Sausen (Tax).

Also of Interest